My Cart [ 0 ]
Home > Chemicals > Inhibitors, Activators, Antagonists, and Agonists > A-Z Inhibitors, Activators, Antagonists, and Agonists > NMS1286937 (NMS-P937)

NMS1286937 (NMS-P937)

NMS-P937

Catalog No. Product Name Size List Price (US$) Quantity
APIM050206 NMS1286937 (NMS-P937) 10 mg 125.00
APIM050206 NMS1286937 (NMS-P937) 50mg 280.00
APIM050206 NMS1286937 (NMS-P937) 100 mg 425.00
APIM050206 NMS1286937 (NMS-P937) 200 mg 700.00
Description

Background Information:

NMS1286937 (NMS-P937) is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. NMS-1286937 selectively and effectively inhibits PLK1 (with IC50 at low nM), inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. It is currently in clinical trials.

Reference:

1. A. Casolaro, et al., The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemia. PLoS One, 2013; 8(3):e58424.
2. B. Valsasina, et al., NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies. Mol Cancer Ther. 2012 Apr; 11(4): 1006-16.* The product has passed the most rigorous analysis for an organic compound, exclusively from CHEMIETEK.

APIM050206: NMS1286937 (NMS-P937)

CAS No.: 1034616-18-6.
Molecular Formula: C24H27F3N8O3.
Molecular Weight: 532.5.
Purity: >99.5% Purity (HPLC, detected at 214 and 254 nm).
QC: HPLC-MS, 1HNMR and Quantitative Elemental Analysis.
Solubility: Soluble in DMSO, and water with 1 eq. of HCl.
Storage: Store at 0°C (short term), -20°C (long term), desiccated.

Related Links

See our Privacy Policy